105 related articles for article (PubMed ID: 27128498)
1. Drosophila melanogaster as a suitable in vivo model to determine potential side effects of nanomaterials: A review.
Alaraby M; Annangi B; Marcos R; Hernández A
J Toxicol Environ Health B Crit Rev; 2016; 19(2):65-104. PubMed ID: 27128498
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and antigenotoxic properties of CeO2 NPs and cerium sulphate: Studies with Drosophila melanogaster as a promising in vivo model.
Alaraby M; Hernández A; Annangi B; Demir E; Bach J; Rubio L; Creus A; Marcos R
Nanotoxicology; 2015; 9(6):749-59. PubMed ID: 25358738
[TBL] [Abstract][Full Text] [Related]
3. Drosophila as a Suitable In Vivo Model in the Safety Assessment of Nanomaterials.
Demir E; Demir FT; Marcos R
Adv Exp Med Biol; 2022; 1357():275-301. PubMed ID: 35583649
[TBL] [Abstract][Full Text] [Related]
4. Drosophila melanogaster as a model organism to study nanotoxicity.
Ong C; Yung LY; Cai Y; Bay BH; Baeg GH
Nanotoxicology; 2015 May; 9(3):396-403. PubMed ID: 25051331
[TBL] [Abstract][Full Text] [Related]
5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic effects of gold nanoparticles induce aberrant phenotypes in Drosophila melanogaster.
Vecchio G; Galeone A; Brunetti V; Maiorano G; Rizzello L; Sabella S; Cingolani R; Pompa PP
Nanomedicine; 2012 Jan; 8(1):1-7. PubMed ID: 22094122
[TBL] [Abstract][Full Text] [Related]
7. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
[TBL] [Abstract][Full Text] [Related]
8.
Demir E
Nanotoxicology; 2020 Nov; 14(9):1271-1279. PubMed ID: 32969292
[TBL] [Abstract][Full Text] [Related]
9. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
Hirose A; Nishimura T; Kanno J
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
[TBL] [Abstract][Full Text] [Related]
10. In vivo genotoxicity assesment of silver nanoparticles of different sizes by the Somatic Mutation and Recombination Test (SMART) on Drosophila.
Ávalos A; Haza AI; Drosopoulou E; Mavragani-Tsipidou P; Morales P
Food Chem Toxicol; 2015 Nov; 85():114-9. PubMed ID: 26169716
[TBL] [Abstract][Full Text] [Related]
11. Genotoxic analysis of silver nanoparticles in Drosophila.
Demir E; Vales G; Kaya B; Creus A; Marcos R
Nanotoxicology; 2011 Sep; 5(3):417-24. PubMed ID: 21039182
[TBL] [Abstract][Full Text] [Related]
12. Risk management of nanomaterials.
Gwinn MR; Tran L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(2):130-7. PubMed ID: 20077523
[TBL] [Abstract][Full Text] [Related]
13. Drosophotoxicology: An Emerging Research Area for Assessing Nanoparticles Interaction with Living Organisms.
Chifiriuc MC; Ratiu AC; Popa M; Ecovoiu AA
Int J Mol Sci; 2016 Feb; 17(2):36. PubMed ID: 26907252
[TBL] [Abstract][Full Text] [Related]
14. Genotoxic testing of titanium dioxide anatase nanoparticles using the wing-spot test and the comet assay in Drosophila.
Carmona ER; Escobar B; Vales G; Marcos R
Mutat Res Genet Toxicol Environ Mutagen; 2015 Jan; 778():12-21. PubMed ID: 25726144
[TBL] [Abstract][Full Text] [Related]
15. Drosophila melanogaster: a model organism for controlling Dipteran vectors and pests.
Zolfaghari Emameh R; Syrjänen L; Barker H; Supuran CT; Parkkila S
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):505-13. PubMed ID: 25198895
[TBL] [Abstract][Full Text] [Related]
16. Drosophila melanogaster as a model system for the evaluation of anti-aging compounds.
Jafari M
Fly (Austin); 2010; 4(3):253-7. PubMed ID: 20473034
[TBL] [Abstract][Full Text] [Related]
17. Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials.
Som C; Nowack B; Krug HF; Wick P
Acc Chem Res; 2013 Mar; 46(3):863-72. PubMed ID: 23110540
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of genotoxic effects of oral exposure to aluminum oxide nanomaterials in rat bone marrow.
Balasubramanyam A; Sailaja N; Mahboob M; Rahman MF; Misra S; Hussain SM; Grover P
Mutat Res; 2009 May; 676(1-2):41-7. PubMed ID: 19486863
[TBL] [Abstract][Full Text] [Related]
19. Can Drosophila melanogaster represent a model system for the detection of reproductive adverse drug reactions?
Avanesian A; Semnani S; Jafari M
Drug Discov Today; 2009 Aug; 14(15-16):761-6. PubMed ID: 19482095
[TBL] [Abstract][Full Text] [Related]
20. [Health risks of engineered nanomaterials and nanotechnologies].
Savolainen K; Vainio H
Duodecim; 2011; 127(11):1097-104. PubMed ID: 21755801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
